Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Lomond Therapeutics Holdings, Inc. ("Lomond Therapeutics"), a clinical-stage biotechnology company dedicated to discovering ...
The Manila Times7h
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
WESTLAKE VILLAGE, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, reported fourth quarter and full year 2024 financial ...
The Manila Times14h
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) ("Calidi” or the "Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it ...
The American Journal of Managed Care9h
ESA Treatment Improves OS in Lower-Risk MDS
Erythropoiesis-stimulating agent (ESA) treatment before or early after regular transfusion therapy improved overall survival ...
Spectral AI, Inc.: Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results
Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView System DALLAS, March ...
CNN on MSN11h
Her research revealed a safety concern with a vaccine. Then the NIH pulled her funding
Dr. Nisha Acharya got a letter from the National Institutes of Health terminating her grant to study the safety and ...
TipRanks on MSN11h
Milestone CRL affirms integrity of clinical data, says H.C. Wainwright
H.C. Wainwright keeps a Buy rating on Milestone Pharmaceuticals (MIST) after the company announced receipt of a complete response letter from the ...
Milestone Pharmaceuticals announces FDA issued CRL for etripamil
Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...
AHA/ASA Journals11h
Streamlining the Pathway to Publish Cardiovascular Research
The American Heart Association (AHA) is thrilled to announce a new collaboration between the New England Journal of Medicine ( NEJM) and the AHA’s flagship journal Circulation. Research authors have ...